Department of Physics and Institute of Medical Engineering, Technische Universität München, James-Franck-Straße, D-85748 Garching, Germany.
Phys Med Biol. 2013 Feb 21;58(4):N37-46. doi: 10.1088/0031-9155/58/4/N37. Epub 2013 Feb 1.
In clinically established-absorption-based-biomedical x-ray imaging, contrast agents with high atomic numbers (e.g. iodine) are commonly used for contrast enhancement. The development of novel x-ray contrast modalities such as phase contrast and dark-field contrast opens up the possible use of alternative contrast media in x-ray imaging. We investigate using ultrasound contrast agents, which unlike iodine-based contrast agents can also be administered to patients with renal impairment and thyroid dysfunction, for application with a recently developed novel x-ray dark-field imaging modality. To produce contrast from these microbubble-based contrast agents, our method exploits ultra-small-angle coherent x-ray scattering. Such scattering dark-field x-ray images can be obtained with a grating-based x-ray imaging setup, together with refraction-based differential phase-contrast and the conventional attenuation contrast images. In this work we specifically show that ultrasound contrast agents based on microbubbles can be used to produce strongly enhanced dark-field contrast, with superior contrast-to-noise ratio compared to the attenuation signal. We also demonstrate that this method works well with an x-ray tube-based setup and that the relative contrast gain even increases when the pixel size is increased from tenths of microns to clinically compatible detector resolutions about up to a millimetre.
在临床已确立的基于吸收的生物医学 X 射线成像中,通常使用具有高原子数的对比剂(例如碘)来增强对比度。新型 X 射线对比方式(如相位对比和暗场对比)的发展为 X 射线成像中使用替代对比剂开辟了可能。我们研究了使用超声对比剂,与基于碘的对比剂不同,超声对比剂也可以用于肾功能不全和甲状腺功能障碍的患者,用于最近开发的新型 X 射线暗场成像方式。为了从这些基于微泡的对比剂中产生对比,我们的方法利用了超小角相干 X 射线散射。这种散射暗场 X 射线图像可以使用基于光栅的 X 射线成像设备与基于折射的差分相位对比和传统的衰减对比图像一起获得。在这项工作中,我们特别表明,基于微泡的超声对比剂可用于产生强烈增强的暗场对比,与衰减信号相比具有更高的对比噪声比。我们还证明了该方法与基于 X 射线管的设备配合良好,并且当像素尺寸从数十微米增加到临床兼容的探测器分辨率(高达约一毫米)时,相对对比度增益甚至会增加。